G20
Conditions
Interventions
Group 1: The screening instrument ist aimed at neurological and psychiatric patients. Since neuropsychiatric syndromes are particularly common in patients with Parkinson's disease we aim to validate t
Sponsors
Universitätsklinikum Köln
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Vision and hearing: Not impaired or adequately corrected (glasses, hearing aid, etc.) Knowledge of German: Sufficient knowledge, alternatively sufficient knowledge of Turkish Language: Sufficient language skills (ACL-K=14) Patients who are in inpatient/outpatient treatment in the Clinic and Polyclinic for Neurology or Clinic and Polyclinic for Psychiatry and Psychotherapy, in Cologne, Germany Cognitive status: No substantial impairment (MoCA > 19) Consent and signed
Exclusion criteria
Exclusion criteria: Vision and hearing impaired, insufficient knowledge of German OR Turkish, Substantial linguistic impairments (ACL-K <14), patients in whom neurological and psychiatric diseases were definitely excluded; Moderate or severe medical conditions that interfere with the ability to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to develop and validate a new, multidimensional screening instrument (Picture-based Neuropsychiatric Syndromes Questionnaire; Pic-NPS) for the mainly speech-free recording of depression, anxiety, apathy, fatigue, mania, impulse control disorders and psychosis in neurological and psychiatric patients (including healthy controls). The current version of the screening instrument comprises 31 items (6 items for depression, 5 items for mania, 5 items for impulse control disorders, 4 items for anxiety, 3 items for fatigue, 3 items for apathy, 5 items for psychosis). The assessment time is approximately 10 minutes. Another aim is the validation of a newly developed language-based screening questionnaire (Neuropsychiatric Syndromes Questionnaire; NPSQ) for the assessment of neuropsychiatric syndromes in patients with Parkinson's disease. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlations of the new screening tool with established questionnaires Determination of cut-off values for the Pic-NPS und NPSQ subscales through assessment of neuropsychiatric syndromes via interview | — |
Countries
Germany
Contacts
Public ContactStefanie Jost
Universitätsklinikum Köln
Outcome results
None listed